Physician

Stanley Mathias Duchman, M.D.

According to 2025 Medicare claims, Stanley Duchman, M.D. (NPI: 1407810377) practices interventional cardiology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is HOUSTON CARDIOVASCULAR ASSOC PA (NPI: 1487746020; TIN: 741941710) and primary practice location at 77069-2393. Duchman is affiliated with the VillageMD Primary Providers ACO II, LLC (ACO ID: D0025), participating under the REACH model.

Duchman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,278 traditional Medicare patients, billed 10,612 HCPCS/CPT codes, and received $2,320,325 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 9,203 prescription claims across 1,109 beneficiaries totaling $1,544,432 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 11 claims. Open Payments data shows 45 records totaling $1,062. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $776,548 to $2,320,325. Similarly, Part D prescription costs have risen steadily, from $825,567 to $1,544,432. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $29,670 to $4,955.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	982	8,257	$776,548
2016	945	8,026	$794,277
2017	978	7,986	$792,000
2018	1,006	7,803	$790,048
2019	1,095	8,439	$924,372
2020	1,049	9,173	$1,504,471
2021	1,119	9,848	$2,102,077
2022	1,195	10,873	$2,368,260
2023	1,251	10,598	$2,208,441
2024	1,278	10,612	$2,320,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	666	6,909	$825,567
2016	688	7,064	$951,329
2017	745	7,394	$967,838
2018	768	7,786	$1,010,734
2019	806	7,836	$1,191,736
2020	834	8,438	$1,372,341
2021	897	8,383	$1,450,918
2022	960	8,566	$1,538,732
2023	1,035	9,099	$1,688,525
2024	1,109	9,203	$1,544,432

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	13	$23,332
2019	N/R	12	$22,096
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$403
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93880	Ultrasound of both sides of head and neck blood flow	797	821	$144
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	855	939	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,113	2,143	$96
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	716	721	$55
J2785	Injection, regadenoson, 0.1 mg	642	2,569	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	361	21,712	$420,568
Xarelto	Rivaroxaban	306	19,887	$354,343
Repatha Sureclick	Evolocumab	267	10,620	$204,812
Entresto	Sacubitril/Valsartan	62	4,183	$92,505
Vascepa	Icosapent Ethyl	69	4,738	$54,408

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$1,062	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stanley Mathias Duchman, M.D.?

Tedicare shows public-source Medicare data for Stanley Mathias Duchman, M.D. (NPI 1407810377), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stanley Mathias Duchman, M.D. have ACO affiliation data?

Stanley Mathias Duchman, M.D. is shown with ACO affiliation data for VillageMD Primary Providers ACO II, LLC (REACH, ACO ID D0025).

What billing organization is linked to Stanley Mathias Duchman, M.D.?

Stanley Mathias Duchman, M.D. is linked to HOUSTON CARDIOVASCULAR ASSOC PA (billing NPI 1487746020) in the available physician profile data.

Does Stanley Mathias Duchman, M.D. have Open Payments data?

Stanley Mathias Duchman, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.